Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature.

Zhang, Lina; Liu, Chengyu; Zhang, Xiaochong; Wang, Changjing; Liu, Dengxiang

Zhang, Lina; Liu, Chengyu; Zhang, Xiaochong; Wang, Changjing; Liu, Dengxiang.

Affiliation

Zhang L; Department of Health Examination Center, Xingtai People's Hospital, Xingtai, 054001, Hebei, China.
Liu C; Graduate School of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Zhang X; Key Laboratory of Cancer Prevention and Treatment, Xingtai People's Hospital, Xingtai, 054001, Hebei, China.
Wang C; Department of Gastrointestinal Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei, China.
Liu D; Institute of Cancer Control, Xingtai People's Hospital, Xingtai, 054001, Hebei, China. rmyy666@163.com.

Funct Integr Genomics ; 23(2): 117, 2023 Apr 04.

Article in En | MEDLINE | ID: mdl-37014493

Subject(s)

Breast Neoplasms; Lung Neoplasms; RNA, Long Noncoding; Humans; Female; Breast Neoplasms/genetics; RNA, Long Noncoding/genetics; ROC Curve; Tumor Microenvironment

Key words

Breast cancer; Immunotherapy; Long noncoding RNAs; Signature; m6A/m5C/m1A/m7G gene

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / RNA, Long Noncoding / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Funct Integr Genomics Journal subject: BIOLOGIA MOLECULAR / GENETICA Year: 2023 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google